Carmen E. Guerra, M.D., M.S.C.E., F.A.C.P.

faculty photo
Ruth C. and Raymond G. Perelman Professor of Medicine
Attending Physician, Hospital of the University of Pennsylvania
Member, Abramson Cancer Center, University of Pennsylvania Medical Center
Attending Physician, Penn Presbyterian Medical Center
Associate Member, Center for Molecular Studies in Digestive and Liver Diseases, University of Pennsylvania
Senior Fellow , Leonard Davis Institute of Health Economics, University of Pennsylvania
Member, Institute for Translational Medicine and Therapeutics, University of Pennsylvania
Founding co-director, UPHS Colorectal Cancer Screening Patient Navigation Program, University of Pennsylvania Health System
Senior Fellow, Center for Health Behavior Research
Member, Center for Health Incentives and Behavioral Economics
Founding Associate Director of Diversity and Outreach, Abramson Cancer Center, University of Pennsylvania
Founding Director, Office of Diversity, Abramson Cancer Center, University of Pennsylvania
Founding Director, Healthy Woman Program/Penn Medicine Breast Health Initiative, University of Pennsylvania Health System
Diversity Search Advisor, Department of Medicine, Perelman School of Medicine
Founding Director, Dr. Edward S. Cooper Leadership Development Program for Women and Diverse PSOM faculty , Perelman School of Medicine
Lead Diversity Search Advisor, Perelman School of Medicine
Senior Fellow, Center for Public Health Initiatives
Vice Chair of Diversity and Inclusion, Department of Medicine, Perelman School of Medicine
Affiliate Member, Penn Center for Cancer Care Innovation at the Abramson Cancer Center
Chair, Vice Chairs of Diversity, Equity and Inclusion, Clinical Practices of the University of Pennsylvania
Department: Medicine

Contact information
Abramson Cancer Center
12-107 South Pavilion
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: (215) 349-5200
Fax: (215) 614-0044
B.A. (Psychobiology)
New York University, 1989.
M.D. (Medicine)
University of Rochester School of Medicine and Dentistry, 1993.
M.S.C.E. (Epidemiology)
University of Pennsylvania School of Medicine, 2006.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Health disparities
Barriers to accessing cancer screening
Barriers to accessing clinical trials
Colorectal cancer screening
Breast cancer screening
Health literacy
Participation in Cancer Clinical Trials by Underserved Populations

Description of Clinical Expertise

Cancer Screening and Prevention
Women's Health
Disease prevention

Description of Other Expertise

Student, Trainee and Faculty Diversity and Inclusion

Selected Publications

Herrera C, Guerra CE, Narayan V, Guzzo TJ, Mamtani R, Lee DJ, Tasian G, Talwar R.: Financial toxicity in prostate cancer survivors: a national cross-sectional assessment of subjective financial burden. Urologic Oncology: Seminars and Original Investigations. In press. 2023.

Barrett NJ, Boehmer L, Schrag J, Benson AB, Green S, Hamroun-Yazid L, Howson A, Matin K, Oyer RA, Pierce L, Jeames SE, Winkfield K, Yang ES, Zwicker V, Bruinooge S, Hurley S, Williams JH, Guerra CE.: An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical Trials. JCO Oncology Practice. In press. 2023.

Finn CB, Tong JK, Alexander HE, Wirtalla C, Wachtel H, Guerra CE, Mehta SJ, Wender R, Kelz RR. : How Referring Providers Choose Specialists for Their Patients: A Systematic Review. J Gen Intern Med 37(13): 3444-3452, Oct 2022 Notes: doi: 10.1007/s11606-022-07574-6. Online ahead of print.

Gerber DE, Tirol JA, McNeill L, Williams EL, Zhu H, Craddock SJ, Leavey PJ, Sadeghil N, Kapinos K, Dornsife DL, Nguyen V, Wileyto EP, Guerra CE. : Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program. Contemporary Clinical Trials 121, Oct 2022.

Guerra CE, Viswanath CE: Advancing Equity in Cancer Clinical Trials: Lessons from the Evidence. JCO Oncol Pract 18(9): 633-634, Sep 2022.

Susan K. Trieman: Working to Reduce Lung Cancer’s Impact on Hard-Hit Communities. Everyday Health Aug 2022 Notes:

Kyle Doherty: Advances in Site Self-Assessment Tools Aim to Bolster Equity in Clinical Trials. OncLive Aug 2022 Notes:

Peck CJ, Roberts SE, Ly C, Hsia H, Aarons CB, Guerra CE, Butler PD. : Embracing Allyship in Academic Surgery: How All Surgeons Can Become Effective Champions for Change. J Amer Coll Surg 235(2): 371-374, Aug 2022.

Oyer RA, Hurley P, Boehmer L, Steeby Bruinooge S, Levit K, Barrett N, Benson A, Bernick LA, Byatt L, Charlot M, Crews J, DeLeon K, Fashoyin-Aje L, Garrett-Mayer E, Gralow JR, Green S, Guerra CE, Hamroun L, Hardy CM, Hempstead B, Jeames S, Mann M, Matin K, McCaskill-Stevens W, Merrill J, Nowakowski GZ, Patel MI, Pressman A, Ramirez AG, Segura J, Segarra-Vasquez B, Williams JH, Williams JE, Winkfield KM, Yang ES, Zwicker V, Pierce LJ.: Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement. J Clin Oncol 40(19): 2163-2171, Jul 2022 Notes: doi: 10.1200/JCO.22.00754. Online ahead of print.

Takvorian SU, Chatterjee P, Mamtani R, Wu Y, Guerra CE, Werner RM, Schpero W: Association Between State Medicaid Policies and Accrual of Black Participants to Cancer Clinical Trials. J Clin Oncol 40(16 Suppl): 1501, Jun 2022.

back to top
Last updated: 10/27/2022
The Trustees of the University of Pennsylvania